AM
Therapeutic Areas
Nautilus Biotechnology Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Voyager Platform - Broadscale Discovery Proteomics | General Proteome Analysis (Drug Target ID, Exploratory Research) | Early Access |
| Voyager Platform - Targeted Proteoform Analysis | In-depth Proteoform Analysis (e.g., Tau, alpha-synuclein in Neurodegenerative Disease) | Early Access |
| Collaboration on Alpha-Synuclein Proteoforms | Parkinson’s Disease Biomarker Discovery | Research Collaboration |
Leadership Team at Nautilus Biotechnology
SP
Sujal Patel
Founder & CEO
PM
Parag Mallick, PhD
Founder & Chief Scientist
KS
Ken Suzuki
Chief Marketing Officer
BS
Birgit Schilling, PhD
Professor and Director of the Mass Spectrometry Core at the Buck Institute for Research on Aging (Collaborator/Webinar Presenter)